Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

An Evolution-Guided Analysis Reveals a Multi-Signaling Regulation of Fas by Tyrosine Phosphorylation and its Implication in Human Cancers.

Chakrabandhu K, Huault S, Durivault J, Lang K, Ta Ngoc L, Bole A, Doma E, Dérijard B, Gérard JP, Pierres M, Hueber AO.

PLoS Biol. 2016 Mar 4;14(3):e1002401. doi: 10.1371/journal.pbio.1002401. eCollection 2016 Mar.

2.

Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death.

Zhu L, Derijard B, Chakrabandhu K, Wang BS, Chen HZ, Hueber AO.

Cancer Lett. 2014 Nov 28;354(2):355-64. doi: 10.1016/j.canlet.2014.08.038. Epub 2014 Sep 6.

PMID:
25199763
3.

Regulation of the intracellular localization of Foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells.

Clavel S, Siffroi-Fernandez S, Coldefy AS, Boulukos K, Pisani DF, Dérijard B.

Mol Cell Biol. 2010 Jan;30(2):470-80. doi: 10.1128/MCB.00666-09. Epub 2009 Nov 16.

4.

Identification of a novel amino acid response pathway triggering ATF2 phosphorylation in mammals.

Chaveroux C, Jousse C, Cherasse Y, Maurin AC, Parry L, Carraro V, Derijard B, Bruhat A, Fafournoux P.

Mol Cell Biol. 2009 Dec;29(24):6515-26. doi: 10.1128/MCB.00489-09. Epub 2009 Oct 12.

5.

SP600125 inhibits Kv channels through a JNK-independent pathway in cancer cells.

Martial S, Giorgelli JL, Renaudo A, Derijard B, Soriani O.

Biochem Biophys Res Commun. 2008 Feb 22;366(4):944-50. Epub 2007 Dec 17.

PMID:
18082627
6.

Involvement of BTBD1 in mesenchymal differentiation.

Pisani DF, Coldefy AS, Elabd C, Cabane C, Salles J, Le Cunff M, Derijard B, Amri EZ, Dani C, Leger JJ, Dechesne CA.

Exp Cell Res. 2007 Jul 1;313(11):2417-26. Epub 2007 Mar 31.

PMID:
17462629
7.

Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle.

Clavel S, Coldefy AS, Kurkdjian E, Salles J, Margaritis I, Derijard B.

Mech Ageing Dev. 2006 Oct;127(10):794-801. Epub 2006 Sep 1.

PMID:
16949134
8.

No evidence for an involvement of the p38 and JNK mitogen-activated protein in inflammatory bowel diseases.

Malamut G, Cabane C, Dubuquoy L, Malapel M, Dérijard B, Gay J, Tamboli C, Colombel JF, Desreumaux P.

Dig Dis Sci. 2006 Aug;51(8):1443-53. Epub 2006 Jul 13.

PMID:
16838116
9.

Mechanisms implicated in the response of system a to hypertonic stress and amino acid deprivation still can be different.

Pastor-Anglada M, Dérijard B, Casado FJ.

J Gen Physiol. 2005 Jan;125(1):41-2. Epub 2004 Dec 13. No abstract available.

10.

The topoisomerase 1-interacting protein BTBD1 is essential for muscle cell differentiation.

Pisani DF, Cabane C, Derijard B, Dechesne CA.

Cell Death Differ. 2004 Nov;11(11):1157-65.

11.

The p38 pathway regulates Akt both at the protein and transcriptional activation levels during myogenesis.

Cabane C, Coldefy AS, Yeow K, Dérijard B.

Cell Signal. 2004 Dec;16(12):1405-15.

PMID:
15381256
12.

The osmoregulatory and the amino acid-regulated responses of system A are mediated by different signal transduction pathways.

López-Fontanals M, Rodríguez-Mulero S, Casado FJ, Dérijard B, Pastor-Anglada M.

J Gen Physiol. 2003 Jul;122(1):5-16. Epub 2003 Jun 16.

13.

Regulation of C2C12 myogenic terminal differentiation by MKK3/p38alpha pathway.

Cabane C, Englaro W, Yeow K, Ragno M, Dérijard B.

Am J Physiol Cell Physiol. 2003 Mar;284(3):C658-66. Epub 2002 Nov 20.

14.

Increased MAPK signaling during in vitro muscle wounding.

Yeow K, Cabane C, Turchi L, Ponzio G, Dérijard B.

Biochem Biophys Res Commun. 2002 Apr 26;293(1):112-9.

PMID:
12054571
15.

Inhibition of myogenesis enables adipogenic trans-differentiation in the C2C12 myogenic cell line.

Yeow K, Phillips B, Dani C, Cabane C, Amri EZ, Dérijard B.

FEBS Lett. 2001 Oct 5;506(2):157-62.

16.

Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies.

Desreumaux P, Dubuquoy L, Nutten S, Peuchmaur M, Englaro W, Schoonjans K, Derijard B, Desvergne B, Wahli W, Chambon P, Leibowitz MD, Colombel JF, Auwerx J.

J Exp Med. 2001 Apr 2;193(7):827-38.

17.

Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation.

Englaro W, Bahadoran P, Bertolotto C, Buscà R, Dérijard B, Livolsi A, Peyron JF, Ortonne JP, Ballotti R.

Oncogene. 1999 Feb 25;18(8):1553-9.

18.

The JNK pathway regulates the In vivo deletion of immature CD4(+)CD8(+) thymocytes.

Rincón M, Whitmarsh A, Yang DD, Weiss L, Dérijard B, Jayaraj P, Davis RJ, Flavell RA.

J Exp Med. 1998 Nov 16;188(10):1817-30.

19.

The neuronal death induced by endotoxic shock but not that induced by excitatory amino acids requires TNF-alpha.

de Bock F, Derijard B, Dornand J, Bockaert J, Rondouin G.

Eur J Neurosci. 1998 Oct;10(10):3107-14.

PMID:
9786205
20.
21.
22.
23.

Selective interaction of JNK protein kinase isoforms with transcription factors.

Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Dérijard B, Davis RJ.

EMBO J. 1996 Jun 3;15(11):2760-70.

24.

MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.

Raingeaud J, Whitmarsh AJ, Barrett T, Dérijard B, Davis RJ.

Mol Cell Biol. 1996 Mar;16(3):1247-55.

25.

Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation.

Bagrodia S, Dérijard B, Davis RJ, Cerione RA.

J Biol Chem. 1995 Nov 24;270(47):27995-8.

26.

Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms.

Dérijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ.

Science. 1995 Feb 3;267(5198):682-5. Erratum in: Science 1995 Jul 7;269(5220):17.

PMID:
7839144
27.

Transcription factor ATF2 regulation by the JNK signal transduction pathway.

Gupta S, Campbell D, Dérijard B, Davis RJ.

Science. 1995 Jan 20;267(5196):389-93.

PMID:
7824938
28.

JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation.

Kallunki T, Su B, Tsigelny I, Sluss HK, Dérijard B, Moore G, Davis R, Karin M.

Genes Dev. 1994 Dec 15;8(24):2996-3007.

29.

Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK.

Minden A, Lin A, McMahon M, Lange-Carter C, Dérijard B, Davis RJ, Johnson GL, Karin M.

Science. 1994 Dec 9;266(5191):1719-23.

PMID:
7992057
30.

Signal transduction by tumor necrosis factor mediated by JNK protein kinases.

Sluss HK, Barrett T, Dérijard B, Davis RJ.

Mol Cell Biol. 1994 Dec;14(12):8376-84.

31.

c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases.

Minden A, Lin A, Smeal T, Dérijard B, Cobb M, Davis R, Karin M.

Mol Cell Biol. 1994 Oct;14(10):6683-8.

32.

An osmosensing signal transduction pathway in mammalian cells.

Galcheva-Gargova Z, Dérijard B, Wu IH, Davis RJ.

Science. 1994 Aug 5;265(5173):806-8.

PMID:
8047888
33.

JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ.

Cell. 1994 Mar 25;76(6):1025-37.

PMID:
8137421
35.

Domain of E. coli translational initiation factor IF2 homologous to lambda cI repressor and displaying DNA binding activity.

Vachon G, Raingeaud J, Dérijard B, Julien R, Cenatiempo Y.

FEBS Lett. 1993 Apr 26;321(2-3):241-6.

36.

Characterization and purification of mesentericin Y105, an anti-Listeria bacteriocin from Leuconostoc mesenteroides.

Héchard Y, Dérijard B, Letellier F, Cenatiempo Y.

J Gen Microbiol. 1992 Dec;138(12):2725-31.

PMID:
1487737
37.

Evidence for a membrane-associated GTP-binding protein in Stigmatella aurantiaca, a prokaryotic cell.

Dérijard B, Ben Aïssa M, Lubochinsky B, Cenatiempo Y.

Biochem Biophys Res Commun. 1989 Jan 31;158(2):562-8.

PMID:
2492803

Supplemental Content

Loading ...
Support Center